Robert F. Kennedy Jr. has treated the U.S. drug epidemic as a priority, both in his independent bid for president and now as President Trump’s nominee for health secretary.
But for all his advocacy surrounding the addiction crisis, Kennedy has never made clear his views on methadone and buprenorphine, the highly effective medications most commonly used to treat opioid use disorder.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
